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Abstract. In previous work, we found that nerve
growth factor (NGF) induced expression of the mRNA
transcript encoding the metalloproteinase transin/stro-
melysin in PC12 cells. Transin was found, moreover,
to be a "late gene product whose expression cor-
related with neurite extension. In this study, various
aspects of the NGF intracellular signaling pathway in
PC12 cells are investigated . We show that the protein
kinase inhibitor staurosporine, but not various other
kinase inhibitors, specifically blocked the NGF induc-
tion of transin. Preliminary characterization of this
staurosporine-sensitive kinase suggest that it does not
correspond to a tyrosine kinase, nor various serine ki-
ERVE growth factor (NGF)l is a polypeptide growth
factor that promotes the survival and differentiation
ofvarious neuronal populations during development
(see Levi-Montalcini, 1987). One experimental model for
studying the effects of NGF is the PC12 rat pheochromocy-
toma cell line (Greene and Tischler, 1976) . In the absence of
NGF, PC12 cellsresemblenormal adrenal chromaffincellsby
various morphological and biochemical criteria (Greene and
Tischler, 1976; Greene et al., 1985). After addition ofNGF
to the culture medium, PC12 cells undergo a transformation
over aperiod ofhoursto days into neuronal cells, elaborating
neurites and expressing various "late" gene products as-
sociated with the neuronal phenotype (Greene, 1984), in-
cluding the neurofilament protein NF-M (Lindenbaum et al.,
1988), GAP-43 (Federoffet al., 1988), and SCG-10 (Stein et
al., 1988). A major issue, however, has concerned the nature
ofthe intracellular signal responsible for the NGF-regulation
of these various late genes.
Various protein kinases have recently been implicated as
part of the intracellular signaling mechanism for NGF The
high-affinity NGF receptor has been shown, for example, to
contain two ligand-binding proteins, one of which corre-
sponds to the trktyrosine kinase protooncogene (Chao et al.,
1. Abbreviations used in this paper: 2-AP, 2-aminopurine; CAT, chloram-
phenical acetyltransferase ; cDNA, complementary DNA; dbcAMP, N6,2'_
O-dibutyryladenosine3',5'-cyclic monophosphate; DOG,dioctanylglycerol;
FGF, fibroblast growth factor; IE genes, immediate-early genes; NF-M,
middle molecular weight protein of the neurofilament triplet; NGF, nerve
growthfactor; PKA, cyclicAMP-dependent protein kinase; PKC, proteinki-
nase C; 6-TG, 6-thioguanine; TPA, 12-O-tetradecanoylphorbol-13-acetate.
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nases, and that it is involved both at the transcriptional
and posttranscriptional levels of transin gene regula-
tion. In contrast to these effects of staurosporine, vari-
ous activators of protein kinases C and A augmented
the NGF induction of transin. Similar effects of these
kinase inhibitors and activators were also observed
with the expression of various immediate-early genes
that have been proposed to mediate the transcriptional
effects of NGF, including cfos and cjun. These data
suggest, therefore, that the NGF induction of transin
mRNA expression involves multiple protein kinases
acting at a number of postreceptor regulatory steps in
the NGF signaling pathway.
1986; Klein et al., 1991; Hempstead et al., 1991; Kaplan et
al ., 1991). In addition, various serine protein kinases have
also been foundto influence the effects of NGF in PC12 cells
(Mann et al., 1989 ; Brady et al., 1990; Costello et al., 1990;
Damon et al ., 1990 ; Glowacka and Wagner, 1990), and may
act at various post-receptor steps in the NGF signaling path-
way. The most compelling evidence involves cyclic AMP
dependent protein kinase (PKA) and protein kinase C (PKC)
(Cremins et al., 1986 ; Mann et al., 1989; Glowacka and
Wagner, 1990; Kalman et al., 1990). NGF has been shown
to activate both ofthese kinases within a few minutes (Heas-
ley and Johnson, 1989) . Various kinase inhibitors, and in
particular inhibitors with some specificity for PKC, block
completely the NGF induction of neurites and various neu-
ronal gene products (Hama et al., 1986; Hall et al ., 1988;
Koizumi et al., 1988; Hashimoto and Hagino, 1989;
Lazarovici et al., 1989). Studies using a variant subclone of
PC12 cell line lacking PKA activities (i.e., the A126-1132
subclone) show that these cells express some, but not all, of
the effects of NGF (Brady et al., 1990).
Other early events which have been suggested to be part
of the NGF signaling pathway include the transient expres-
sion of various "immediate-early (IE) gene products, in-
cluding Fos, Jun, and NGFI-A (Greenberg et al., 1985;
Kruijer et al., 1985 ; Milbrandt, 1986; Kujubu et al., 1987;
Bartel et al., 1989 ; Wu et al., 1989; Sheng and Greenberg,
1990). mRNA transcripts encoded by these genes have been
found to increase within 10-15 min of NGF addition, and
then to decrease to basal levels within hours. The proteins
encoded by these IE genes are also expressed transiently(Curran and Morgan, 1985) and are believed to recognize
specific regulatory elements in the genome and act as tran-
scriptional activators (Rauscher et al., 1988; Mitchell and
Tijan, 1989; Morgan and Curran, 1989; Gizang-Ginsberg
and Ziff, 1990; Sheng and Greenberg, 1990).
The nature of the coupling between IE and late gene ex-
pression is, however, unclear. Depolarization of PC12 cells
with high K+ or the addition of various growth factors other
than NGF, for example, induce expression of cfos, cjun,
and NGFIA mRNA transcripts in PC12 cells (Bartel et al.,
1989; Wu et al., 1989), but do not induce neuronal differen-
tiation (Greene et al., 1985 ; Machida et al., 1989) . It has
been suggested, therefore, that combinations of specific IE
gene products may act in concert as tertiary messengers in
NGF signaling, coupling early events (e.g. kinase activation)
into long-term responses involving differential transcription
of late genes (Greene et al., 1985; Levi et al., 1988; Sheng
and Greenberg, 1990). Alternatively, induction of these IE
genes may not be involved in neuronal differentiation at all,
but may direct other events associated with these growth fac-
tors, such as changes in cellular metabolism or mitogenesis
(Greene et al., 1985 ; Boonstra et al., 1987).
Transin (or "stromelysin-1" or "matrix metalloproteinase-3"
[Matrisian, 1990]) is a metalloproteinase under transcrip-
tional control by various growth factors in a variety of cell
types (Matrisian et al., 1986; Machida et al ., 1988 ; Kerr et
al., 1988, 1990) . In rat fibroblasts, transin is induced by
epidermal growth factor (EGF) (Matrisian et al ., 1986), and
this EGF induction requires activation of PKC (McDonnell
et al., 1990) . In PC12 cells, in contrast, transin is induced
by NGF, but not EGF (Machida et al., 1989). In the absence
ofNGF, transin mRNAlevels are undetectable in PC12 cells,
but increase over 100-fold in 24 h after addition of NGF
(Machida et al ., 1989), making transin one ofthe most NGF-
responsive gene products described (e.g., Leonard et al.,
1987; Federoff et al ., 1988; Stein et al., 1988 ; see Mil-
brandt, 1986, 1987). Nuclear run-on assays showed, more-
over, that this increase in transin mRNA levels is at least
partly due to de novo transcription (Machida et al., 1989) .
Various aspects oftranshfs regulation by NGF are charac-
teristic of the late gene products (Greene et al., 1985;
Machida et al., 1989). The time course of transin mRNA ex-
pression, for example, coincides closely with that of the
mRNA encoding neurofilament protein, NF-M (Linden-
baum et al., 1988; Machida et al., 1989). In addition, the
NGF induction oftransin mRNA expression requires protein
synthesis, presumably due to a requirement for induction of
various transcriptional activator proteins.
There are two reasons to believe a priori that the regulation
oftransin by NGF in PC12 cellsmay involve specific IE gene
products. First, the promoter region ofthe transin gene con-
tains DNA consensus sequences corresponding to binding
sites for various IE genes induced in PC12 cells by NGF
(Matrisian et al., 1985; Bartel et al., 1989) . These sequences
include an NGFI-A recognition sequence (also known as zif
268, egr-1, Krox 24 and TIS 8; i .e., GCGG/TGGGCG) atpo-
sition -408 to the transcription start site which is recog-
nized by the NGF-IA gene product (Christy and Nathans,
1989), and an APl consensus sequence (i.e., TGAGTCA) at
position -68. API sequences are believed to bind the tran-
scriptional activating proteins, Fos and Jun, and members of
their gene families (Kouzarides and Ziff, 1988; Halazonetis
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et al., 1988; Rauscher et al ., 1988). The NGFI-A and API
consensus sequences are found, moreover, in a 750-bp re-
gion ofthe transin promoter region, which confers NGF re-
sponsiveness in transient transfection experiments (Machida
et al., 1989). A second reason to believe that various IE
genes, and members of the Fos and Jun families in particular,
are involved in transin regulation comes from the studies of
Kerr et al. (1988). In these experiments, the EGF induction
ofthe transin gene in fibroblasts was inhibited by the expres-
sion of anti-sense cfos transcripts or by cotransfection with
synthetic copies of the API sequence, presumably titrating
out the effects of API binding proteins.
In this paper, we examine various aspects ofthe intracellu-
lar signaling pathway by which NGF induces various late
gene products, as well as neurite extension, in PC12 cells.
We show that the NGF-induction oftransin gene expression
requires the activation of a potentially novel staurosporine-
sensitive protein kinase, which acts both at the transcrip-
tional and posttranscriptional levels. Activation of various
other serine protein kinases, on the other hand, do not seem
to be necessary for transin expression, but do serve to poten-
tiatethe effects ofNGF . These studies suggest, therefore, that
the NGF induction oftransin gene expression involves multi-
ple protein kinases that act at various steps in the signaling
pathway and that may mediate different NGF-associated
events.
Materials andMethods
ProteinKinase InhibitorsandActivators
Staurosporine was purchased from Kamiya Biomedical Co. (Thousand
Oaks, CA). H-7, H-8, and HA1004 were obtained from Seikagaku America,
Inc. (St. Petersburg, FL). All other protein kinase inhibitors and activators
were obtained from Sigma Chemical Co. (St. Louis, MO).
Cell Culture
Stock culturesofPC12 cells were grown in "basalmedium,"which consisted
of Leibowitz L15 culture medium (Gibco Laboratories, Grand Island, NY)
supplemented with 6 mg/ml D-(+)-glucose and a vitamin mixture (Mains
and Patterson, 1973) (Sigma Chemical Co.), as well as the following Gibco
products: FBS (5 %), horse serum (5 %), glutamine (2 mM), penicillin (50
U/ml), and streptomycin (50 wg/ml) . For all experiments, -5 x 105 cells
were plated onto 10 cm Primaria dishes (Falcon Labware, Oxnard, CA).
The next day, the culture medium was removed and replaced with "N2-
supplemented" medium (Bottenstein and Sato, 1979), consisting of basal
medium without serum, but supplemented with the following Sigma prod-
ucts: insulin (5 pg/ml), transferrin (100 pg/ml), sodium selenite (30 nM),
putrescein (100 AM), and progesterone (20 nM). The next morning, NGF
(50 ng/ml) and the various PKC activators or inhibitors were added directly
to this N2-supplemented medium.
Morphometric Analysis
Random microscopic fields were photographed using a Zeiss IM35 inverted
microscope. The negatives were then examined, andthe proportion ofPC12
cells expressing neurites determined (neurites wereoperationally defined as
cell processes at least two cell diameters in length). Typically, three to five
cultures were examined per condition, and ten photographs taken per cul-
ture. Statistical comparisons were made using the Newman-Keuls multi-
comparison test, and statistically significant differences were defined as
P < 0.05.
RNA BlotAnalysis
Cells were harvested and total cellular RNA wasisolated, as describedpre-
viously (Machida et al., 1988, 1989). RNA preparations (10-20 pg/lane)
were then subjected to electrophoresis in 1.2% agarose gels containing
10382.2 M formaldehyde and blotted onto Nytran membranes (Schleicher &
Schuell, Keene, NH) . Thepositions ofthe ribosomal RNA bands were then
visualized by acridine orange staining as viewed on an ultraviolet light
transilluminator. Prehybridization and hybridizationwereperformed as de-
scribed previously (Machida et al ., 1988, 1989), using approximately 10 8
cpm/ug of 32P-labeled nick-translated prRl plasmid containing a 1.6-kb
transincDNA insert. After hybridization for 16 h at 42°C, the membranes
were washed briefly in 2x SSC buffer (Maniatis et al ., 1982) containing
0.1% SDS (SDS) at room temperature followed by a last wash with 0.2x
SSC buffercontaining 0.1% SDS at 60°C. These membranes were then ex-
posed toX-OMAT X-ray film(Eastman Kodak, Rochester, NY) with inten-
sifying screens for 1-2 d at -80°C. For stripping, the RNA blots were
treated for 1 h at 70°C with a solution consisting of 50% formamide, 50
mM EDTA and 100 mM Tris buffer (pH 7.4) . In some cases, semi-
quantitative analysis ofmRNA levels wasperformed, using a scanning den-
sitometer (Hoefvr Scientific Instruments, San Francisco, CA) . In these ex-
periments, autoradiographic densities of the cyclophilin mRNA band in
each lane served as an internal control forRNA loading artifacts (Danielson
et al ., 1988 ; Machida et al ., 1989) .
NuclearRun-On Assays
Preparation of nuclei and transcriptional run-on assays were carried out as
described previously (Machida et al ., 1988, 1989) . Briefly, nuclei contain-
ing similar amounts of radioactivity (2 x 107 cpm/ml) were hybridized for
2 d at 42°C with either transin, NF-M, cyclophilin or pBR322 DNA (10
jig) immobilized on Nytran membranes . After hybridization, the mem-
branes were washed two times in 2x SSC buffer at room temperature and
then in 0.2x SSC buffer (with 0.1% SDS) at 60°C. The hybridized mem-
branes were thenexposed toX-OMAT x-ray film (Eastman Kodak) with in-
tensifying screens for 9 d at -70°C, and thenthe films were scanned as de-
scribed above. Negative controls in these studies included blots with
immobilized pBR322 DNA and showed no detectable hybridization .
Transient Transfection Assays
The method ofGorman et al . (1982), as detailed in Machida et al . (1989),
was used . Briefly, PC12 cells were first plated at a density of 2 x 105 cells
per 10 cm plate. The next day, fresh medium containing a calcium phos-
phate precipitate (Gorman et al ., 1982) with 7 pg of p750tfRCAT (Kerr et
al ., 1988) was added to the cultures . After a 4-h incubation, the medium
was removed and the cells were treated with 15% glycerol in HBSS (Gibco
Laboratories) for 2 min. The cells were then washed twice and cultured
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overnight in "N2-supplemented" medium . The next day, NGF and/or the
various PKC inhibitors or activators were added to the culture medium, and
the cultures were then incubated an additional 24 h . At that time, the cells
were harvestedand the extracts assayed for chloramphenicol acetyltransfer-
ase (CAT) activity using the method of Gorman et al . (1982), as modified
by Seasholtz et al . (1988) . After autoradiography, radioactive spots corre-
sponding to acetylated and nonacetylated forms of chloramphenicol were
cut out and counted in a Beckman scintillation counter (Beckman Instru-
ments, Fullerton, CA) .
Results
E ffects ofKinase Inhibitorson the NGF Induction
of Transin andNF-MmRNA Expression
To determine whether the NGF induction of transin mRNA
expression required kinase activation, various protein kinase
inhibitors were screened for their ability to inhibit this in-
duction . In these experiments, PC12 cells were cultured for
24 h in NGF-containing medium supplemented with these
various inhibitors, and then the cultures were harvested and
RNA blotting studies performed . Fig. 1 A is an autoradio-
graph from two such experiments and shows that the nu-
cleotide analogues 2-aminopurine (2-AP) and 6-thioguanine
(6-TG) partially blocked the NGF induction oftransin (com-
pare lanes J and K, respectively, with lane 1), but that 5 nM
staurosporine completely blocked this induction (compare
laneC with lane B) . In contrast, various other kinase inhibi-
tors had little or no effect on the NGF induction of transin,
including the PKC inhibitors sphingosine and H-7 and the
cyclic nucleotide-dependent kinase inhibitors H-8 and HA-
1004 . It should be noted that none of these inhibitors in-
duced transin mRNA expression in the absence ofNGF. It
should also be noted that these concentrations of H-8 and
HA-1004 were able to inhibit cyclic nucleotide-dependent
protein kinase activities in broken cell preparations ofPC12
cells, as well as in live cultures (data not shown) . These data
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Figure 1. RNA blot showing the
effects of various protein kinase
inhibitors on the NGF induction
of transin mRNA levels (A) and
NF-M mRNA levels (B) . PC12
cells were cultured for 24 h in the
absence or presence ofNGF (50
ng/ml) or NGF plus various pro-
tein kinase inhibitors (staurospo-
rine, 5 nM ; sphingosine, 5 pM ;
H-7, 6AM ; H-8, 2pM ; HA-1004,
4 juM) . At the end of this period,
the cultures were harvested and
RNA blot analysis was per-
formed . In all cases, blots probed
for transin or NF-M were stripped
(Machida et al ., 1989) and re-
probed for cyclophilin to control
for RNA loading artifacts . Note
that staurosporine completely
blocked the NGF induction of
transinmRNA andNF-MmRNA
expression above basal levels .
Also note that2AP and 6-TG par-
tially inhibited the NGF-induc-
tion of both transin and NF-M
mRNA levels .suggest that activation of neither the cyclic nucleotide-de-
pendent protein kinases norPKC are necessary for theNGF
induction of transin gene expression .
Additional evidence that activation of cAMP-dependent
protein kinase (PKA) is not involved in the NGF induction
of transin mRNA levels come from studies using the A126-
1B2 subclone of PC12, which lacks detectable PKA II activi-
ties (VanBuskirk et al ., 1985) . In these studies, A126-1B2
cells were found to display normal levels of NGF-induced
transin mRNA expression (data not shown) .
To determine whether the effects of these kinase inhibitors
were specific to transin, or whether other NGF late genes
would be similarly affected, duplicate RNA blots to those de-
scribed above,were probed for expression of the mRNA en-
coding the neurofilament protein "NF-ML- another NGF-
inducible late gene product in PC12 cells (Lindenbaum et
al ., 1988) . Fig. 1 B shows that 2-AP was most effective at
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Figure 2 . Effects of staurosporine
on the NGF-induced time course
of transin mRNA expression (A)
and neurite outgrowth (B-E) .
PC12 cells were cultured for vari-
ous periods of time in the pres-
ence ofNGF alone (lanes N) or
NGF plus staurosporine (10 nM ;
lanes NS), and then harvested for
RNA analysis . Note that stauro-
sporine completely blocked the
NGF induction of both transin
mRNA expression and neurites .
inhibiting the NGF induction ofNF-M, reducingmRNA lev-
els below basal levels of expression (compare lane J with
lanesH and I) . This inhibitory effect of2AP was also seen
with basal levels of NF-M expression (data not shown) . In
addition, 6TG and staurosporine were also found to partially
inhibit the NGF-induction of NF-M (i.e ., compare lane K
with I and lane C with B), although the extent of inhibition
varied somewhat between experiments. In contrast, neither
sphingosine, H7, H8, nor HA-1004 were found to affect the
NGF induction ofNF-M mRNA levels . These experiments
were performed three times with qualitatively similar results .
E ffectsofStaurosporine onNeunte Extension
Since staurosporine was most effective at blocking the NGF
induction of transin, further characterization ofits effects on
PC12 cells were carried out. Previously, Hashimoto and
1040Hagino (1989) had shown that staurosporine had differential
effects on neurite formation in a subclone ofPC12 cells (i.e.,
PC12h) cultured in serum-containing medium, with lower
concentrations of staurosporine (3-10 nM) blocking the
NGF induction of neurites, and higher concentrations (e.g .,
100 nM) inducing neurites in the absence ofNGF (see also
Tishler et al ., 1990, 1991) . To determine whether staurospo-
rine had similar effects on neurite formation under our
serum-free culture conditions, and to correlate these effects
with transin mRNA expression, cultures were treated with
either NGF alone or NGF plus staurosporine . At various
periods of time, the cultures were photographed and then
harvested for RNA blot analysis . Fig . 2 A is an RNA blot
showing the time course of transin expression following ad-
dition of either NGF (lanes N) or NGF plus low concentra-
tions of staurosporine (lanes "NS"), and demonstrates that
staurosporine blocked completely the NGF-induction of the
transin transcript at all time points . Fig . 2 B represents the
morphometric analysis of neurite extension in these same
cultures, and shows that staurosporine also inhibited the
NGF induction of neurites . Whereas over half of the PC12
cells in NGF-treated cultures expressed neurites at96 h, only
3% of the cells expressed neurites in the presence of NGF
plus 10 nM staurosporine. C-E are photomicrographs from
representative cultures at 4d and show that the NGF/stauro-
sporine-treated cultures (E) had similar cell densities to those
in NGF-supplemented medium (D), as well as control cul-
tures (C) . These photomicrographs also show that the stau-
rosporine-treated cultures appeared healthy, and did not dis-
play any of the characteristic features of cytotoxicity, such
as vacuoles or cell detachment . In contrast, similar experi-
ments using the relatively higher concentrations of stauro-
sporine reported to elicit neurite extension (i.e ., 100 nM ;
Hashimoto and Hagino, 1989) proved to be cytotoxic under
our culture conditions (data not shown) .
E ffects ofPKC Downregulation on theNGFInduction
ofRansin mRNA Expression
Staurosporine has been reported to be a potent inhibitor of
various protein kinases in rat cells, with somewhat higher
specificity for PKC (Tamaoki et al ., 1988) . To determine,
therefore, whether activation of PKC was necessary for the
NGF induction of transin mRNA expression, a second
strategy was used to deplete PC12 cells to PKC. In these ex-
periments, cultures were pretreated with various concentra-
tions of the phorbol ester 12-O-tetradecanoyl phorbol 13-
acetate (TPA), which has been shown to downregulate PKC
in a variety ofcell types (Foutnier and Murray, 1987 ; Inagaki
et al ., 1986 ; Cooper et al ., 1989), including PC12 cells (Sig-
mund et al ., 1990 ; Vyas et al ., 1990) . Previous studies by
Matthies et al . (1987) had found, for example, that treatment
of PC12 cells with 1.0 wM TPA resulted in the loss of >95
ofPKC activity, but did not affect significantly the levels of
other kinases . In our experiments, PC12 cell cultures were
pretreated for 24 h with various concentrations of TPA, and
then NGF was added to this medium for an additional 24-h
period . At that time, the cultures were harvested for RNA
blot analysis . Fig. 3 shows that there were no significant
differences in the NGF-induced levels oftransinmRNA after
pretreatment with various concentrations of TPA, including
1.0,uM (i.e ., compare lane F with lane B) . Similarly, PKC
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Figure 3. RNA blot showing
thatPKC downregulatedPC12
cells did not display decreased
NGF-induced levels oftransin
mRNA . PC12 cells were cul-
tured for 24 h in the absence
(lanes A and B) or presence of
various concentrations of TPA (lane C, 10 nM ; lane D, 100 nM ;
lane E, 500 nM ; lane F, 1000 nM) . At the end ofthis period, NGF
was added to the culture medium corresponding to lanes B-F for
an additional 24 h, and then the cells were harvested forRNA blot
analysis . Note that even the highest concentrations ofTPA did not
significantly reduce the NGF-induction of transin mRNA expres-
sion (compare lane F with lane B) .
downregulated cells displayed no significant decrease in the
NGF induction ofNF-M mRNA expression or neurite exten-
sion (data not shown) . These data indicate, therefore, that
activation of PKC is probably not a necessary step in the
NGF-induction of various late gene products, nor in the
elaboration of neurites (see also Damon et al ., 1990) .
E ffects ofKinaseActivators on theNGFInduction
ofTlransin andNF-MmRNA Expression
Although activation ofPKC or the cyclic nucleotide-depen-
dent protein kinases do not seem to be necessary for NGF
action, they may still serve to augment the inductive effects
ofNGF on late gene expression in PC12 cells, as had been
previously shown with neurite extension (Hall et al., 1988) .
To test this possibility, various protein kinase activators were
screened for their ability to synergize with NGF in inducing
transin and NF-M mRNA expression . In these experiments,
PC12 cells were cultured for 24 h in NGF-containing
medium supplemented with various kinase activators and
then the cultures were harvested and RNA blotting studies
performed . Fig . 4 A shows that low concentrations of TPA,
which activate PKC in PC12 cells (Heasley and Johnson,
1989), augmented the NGF-induction of transin mRNA lev-
els (compare lanes C withB) . Similarly, addition ofthePKA
activators dibutyryl cAMP (dbcAMP) and forskolin also
served to augment the NGF-induction of transin (compare
lanes D and E, respectively, with laneB) . In contrast, vana-
date, which is believed to potentiate the actions of various
tyrosine kinases by inhibiting phosphotyrosyl phosphatases
(Swarup et al., 1982 ; Yonemoto et al ., 1987), had no
significant effect in this regard (compare laneF with laneB) .
It should be noted that none of these agents induced detect-
able levels of transin mRNA expression in the absence of
NGF either alone (lanes K-M) or in various combinations
(lanes GJ) . This experiment has been performed three
times with similar results.
When the effects of these kinase activators on transin
mRNA induction were compared with those ofNF-M, some
differences were noted . Fig . 4 B shows that TPA and vana-
date each augmented the NGF-induction ofNF-M (compare
lanes C and F with lane B), but that neither of the PKA
activators-dbcAMP or forskolin-had a significant effect in
this regard (compare lanes D andE with lane B) . In the ab-
sence ofNGF, vanadatealso increased the basal levels ofNF-M
expression somewhat (compare lanes H andK or lanesM
1041and A) . This experiment was performed three times with
similar results .
Ransient 7lransfection Studies
In previous work, we found that the recombinant plasmid
p750TRCAT conferred NGF responsiveness in transient
transfection assays (Machida et al ., 1989) . This plasmid con-
tains 750-bp ofthe promoter region immediately adjacent to
the transcriptional start site of the transin gene fused to the
reporter gene chloramphenicol acetyltransferase (CAT) (Kerr
et al ., 1988) . To determine whether this region ofthe transin
promoter mediated the effects of these kinase activatorsand
inhibitors, PC12 cells were transfected with the p750TRCAT
plasmid, cultured for 24 h in the presence of NGF plus or
minus various kinase activators or inhibitors, and then as-
sayed forCAT activity. Fig . 5 is a representative experiment
of four such treatments, and shows that the PKC activators
TPA and dioctanoylglycerol (DOG) augmented the NGF in-
duction ofCAT activities in transfected PC12 cells (i.e ., com-
pare lanes NT and ND with lane N) . Similar augmentation
ofCATinduced by NGF was observed with the PKA activa-
tors dibutyryl cAMP and forskolin (data not shown) . Fig . 5
also shows that staurosporine inhibited the NGF induction
of CAT activity by -25% (i.e ., compare lane NS with lane
N), and that this inhibition was statistically significant (P <
0.05) . This inability of staurosporine to block completely the
inductive effects ofNGF in these transient transfection assays
may indicate either that some of staurosporine's effects are
mediated by a regulatory element(s) not present in the 750-bp
transin promoter region, or that staurosporine acts posttran-
scriptionally .
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Figure 4. Effects of various pro-
tein kinase activators on the NGF
induction oftransin mRNA levels
(A) andNF-MmRNA levels (B) .
PC12 cells were cultured for 24 h
in the absence (lanes A and H) or
presenceofNGF (50ng/ml)(lanes
B and 1) or NGF plus various
protein kinase activators, includ-
ing TPA (lane C ; 10 nM), dibu-
tyrylCAMP (1.0mM ; lane D), for-
skolin (10AM ; lane E), vanadate
(10 Am ; lane F) . Other cultures
were treated with these kinase ac-
tivators alone (lanes K-M) or in
combination (lanes G-J) . Note
that the PKC activator TPA aug-
mented theNGF induction ofboth
transin and NF-M mRNA expres-
sion ; and that the PKA activators
dbcAMPand forskolin augmented
the NGF induction oftransin, but
not NF-M, mRNA levels. Also
notethatvanadate (10AM ; laneF)
augmented the NGF-induction of
NF-M, but not transin, mRNA
levels .
Effects ofKinase Inhibitors on Immediate-Early
Gene Expression
The transient transfection studies described above suggest
that the transin promoter containsDNA sequences which are
responsive to these kinases . This 750-bp region is known to
contain DNA binding sites for transcription factors encoded
by the IE genes, NGFI-A and the API proteins, Fos and Jun .
If these IE gene products are also part oftheNGF signaling
pathway, then the NGF induction of these various IE gene
products should be similarly affected by the same set ofpro-
tein kinase inhibitors and activators. To test this prediction,
PC12 cells were cultured for 30 min in the presence ofNGF
plus various kinase inhibitors, and then the cultures were
harvested forRNA analysis . Fig. 6 represents a quantitative
analysis of the autoradiographic densities from three experi-
ments in which these RNA blots wereprobed for cfos (black
bars), cjun (stripedbars), andNGFI-A transcripts (stippled
bars) . To facilitate comparisons, autoradiographic density
values were normalized to cyclophilinmRNA levels as an in-
ternal control, and then were calculated as a percentage of
cultures treated with NGF alone . These experiments show
that staurosporine or 2-AP inhibited significantly the NGF
induction ofthe cfos and cjun transcripts, but did not affect
induced levels of theNGFI-A transcript . In contrast, neither
the PKC inhibitor sphingosine, nor the cyclic nucleotide-de-
pendent protein kinase inhibitors H-7, H-8, and HA-1004
significantly affected the NGF induction of any of these IE
genes .
To determine whether activation of PKC would augment
the NGF-induction ofthese IE genes, experiments were per-
formed using thePKC activator, TPA . In these studies, PC12
1042B
cells were cultured for various periods of time in the pres-
ence of NGF (lanes N), NGF plus TPA (lanes NT), TPA
alone (lanes T), or without any additives (lanes C), and then
harvested for RNA . Fig . 7 shows that TPA augmented the
NGF-induction of transcripts for all three of these IE genes
Figure 6 . Effects of various protein kinase inhibitors on the NGF
induction of cfos mRNA levels (black bars), cjun mRNA levels
(stripedbars), or NGFI-AmRNAlevels (stippledbars) . PC12 cells
were cultured for 30 min in the presence ofNGF alone (lane N)
or NGF plus one of the protein kinase inhibitors described in the
legend to Fig . 1 . Densitometric analysis of autoradiographs from
three experiments were scanned, and then the raw data were ad-
justed for differences in cyclophilin mRNA densities. Cultures
treated withNGF alone were set at 100 (arbitrary units), and statis-
tical comparisons were performed using the Newman-Keuls multi-
comparison test . Error bars refer to standard errors of the mean ;
asterisks mark conditions in which there was a statistically sig-
nificant difference (i.e ., P < 0.05) from cultures treated with
NGF alone .
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(e.g., compare lane6with lane 3), ranging from about three-
fold (i .e., over NGF alone) for cfos and NGFI-A (A and C,
respectively) to about fivefold for the cjun transcripts (B) .
In the absence ofNGF, TPA also induced these transcripts,
albeit at lower levels ofexpression (compare lane 8 with lane
9), as had been reported earlier (Kujubu et al ., 1987) . Simi-
lar results showing augmentation ofthe NGF-induction ofIE
gene expression were also seen when the PKC activator,
DOG, was substituted for TPA (data not shown) .
EffectsofStaurosporine Addition
afterIEGene Expression
It has been suggested that kinase activation is likely to be up-
stream of IE gene expression in the NGF signaling pathway
(Levi et al ., 1988) . If so, then the addition of staurosporine
after the transient expression of the IE genes has occurred
would have little effect on transin mRNA expression . To test
this prediction, staurosporine was added either 30 minutes
following NGF-addition (i.e ., at the peak ofbothmRNA and
protein expression ofthe Fos and Jun gene products [Curran
and Morgan, 1985 ; Greenberg et al., 1985 ; see also Fig . 7])
or 4 h afterNGF addition (i.e ., after Fos and JunmRNA and
protein levels have returned to basal levels of expression) . At
the end of 24 h, the cultures were harvested and RNA blot-
ting studies performed . Fig . 8 A shows that addition of stau-
rosporine either 30 min (lane C) or 4 h after NGF addition
(lane D) completely blocked the NGF induction of transin
mRNA expression . In contrast, NF-MmRNA levels did not
seem to be affected significantly by the delayed addition of
staurosporine at 4 h (Fig . 8 B, lane D) . This experiment was
performed three times with similar results . These data indi-
cate, therefore, that at least some of the inhibitory effects of
staurosporine on transin mRNA expression occur after the
Fos and Jun proteins are no longer present .
NuclearRun-On Experiments
To test directly whether staurosporine inhibited de novo tran-
sinmRNA expression, nuclear run-on assays were then per-
formed . In these experiments, PC12 cultures were treated for
4 h with NGF in the presence or absence of staurosporine,
and then the cells were harvested and nuclei isolated . Fig.
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Figure S . Transient transfection
assay using p750TRCAT. PC12
cells were transfected and then
cultured for 24 h in the presence
ofNGF (lanes N), NGF plus TPA
(lanes NT), NGF plus dioctanyl-
glycerol (lanes ND), orNGF plus
staurosporine (lanes NS) . A is a
representative experiment ;B rep-
resents the resultsoffour separate
experiments and shows the mean
values plus the standard errors of
the mean . Note that NT,ND, and
NT cultures all expressed CAT
specific activities which differed
to a statistically significant degree
(i .e ., P < 0.05) from those of
N cultures, as determined using
a Newman-Keuls multicompari-
son test .Figure 7 . Effects of the PKC activator TPA on the NGF induction
of cfos (A), cjun (B) or NGFI-A levels (C) . PC12 cells were cul-
tured for various periods of time in the absence (lanes marked C)
or presence of NGF (lanes marked N) or NGF plus 10 nM TPA
(lanes marked NT), and then were harvested forRNA blot analysis .
Note that TPA augmented the NGF-induced expression of all three
IE transcripts, and with a similar time course .
9A shows thatNGF increased significantly the rate oftransin
mRNA expression, and that the presence of staurosporine did
not significantly inhibit this NGF induction (compare condi-
tions N and NS) . Control cultures, in which cells were
treated with staurosporine alone (S), were not significantly
different from those ofuntreated cultures (C) . Negative con-
trols in these experiments included analysis of the rates of
cyclophilinmRNA expression, and showed that neitherNGF
nor staurosporine, either alone or in combination, affected
this rate of transcription (Fig . 9 B) . To determine whether
the delayed addition of staurosporine affected the rate of
NGF-induced transin mRNA expression, some cultures
Figure 8 . Effects of stauro-
sporine-addition after IE gene
expression has occurred on
NGF-induced aamin andNF-M
mRNA expression . PC12 cell
cultures were cultured in the
absence (lane A) or presence of NGF (lanes B-D), and then
staurosporine (5 nM) was added to the culture medium at either 30
min (lane C) or 4 h (laneD) . At the end of 24 h, the cultures were
harvested forRNAblot analysis. Note thataddition of staurosporine
at 4 h blocked the NGF-induction of transin mRNA levels, but had
little effect on NGF-induced NF-M mRNA levels .
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Figure9 Nuclear run-onassays showing the effectsofstaurosporine
on de novo transin mRNA expression (A) and cyclophilin mRNA
expression (B) as a control . PC12 cells were treated for a period
of4 h with freshmedium (C),NGF (50 ng/ml ;N),NGF plus stauro-
sporine (5 nM ; NS), staurosporine (S), NGF alone for 30 min fol-
lowed by addition of staurosporine (N30m/NS), or NGF alone for
2 h followed by addition of staurosporine (N2h/NS) . At the end of
this 4-h treatment, the cells were harvested, nuclei isolated, nuclear
run-on assays performed, and autoradiographs prepared, as de-
scribed in Materials and Methods . Error bars refer to standard er-
rors ofthe mean offour densitometric scans . Asterisks refer to con-
ditions in which there was a statistically significant difference
(P< 0.05) from cultures treated with fresh medium alone (i .e ., C),
as determined by t test analysis.
were given staurosporine at various times after the addition
ofNGF . Fig . 9A shows that addition of staurosporine at ei-
ther 30 min (N30m/NS) or 2 h (N2h/NS) blocked the NGF-
induced increased rate of transin mRNA expression. And
again, controls for the rate of cyclophilin mRNA production
showed no significant differences (Fig . 9 B) . These experi-
ments were performed twice with qualitatively similar results.
Discussion
In this paper, we examine the intracellular signaling mecha-
nism whereby NGF induces transin gene expression inPC12
cells, and in particular, the possible roles of various protein
kinases and IE gene products . Our results suggest that activa-
tion of a staurosporine-sensitive protein kinase (or kinases)
is necessary for this induction, and that this kinase may act
1044at a number ofpostreceptor steps in the NGF signaling path-
way, including both transcriptional and posttranscriptional
steps. These data are consistent with the notion that the NGF
signaling pathway involves multiple protein kinases which
regulate the various effects of NGF.
The NGFInduction ofT}ansin Involves a
StaurospoHne-sensitive Serine Kinase
There are several reasons to believe thatactivation ofa novel,
staurosporine-sensitive protein kinase is a necessary step in
the NGF signaling pathway inducing transin gene expres-
sion, and probably NF-M expression as well. We found, for
example, that low concentrations of staurosporine com-
pletely blocked the NGFinduction ofboth transin and NF-M,
but did not affect expression of a non-NGF-regulated gene
product- cyclophilin. Although staurosporine has a broad
specificity at higher concentrations, it should be noted that
the concentrations used in these studies (i.e., 5 nM) is be-
low the K for inhibition of many protein kinases, including
the cyclic nucleotide-dependent protein kinases, myosin light
chain kinase (Tamaoki et al., 1986) and the platelet-derived
growth factor receptor tyrosine kinase (Secrist et al., 1990).
In contrast to these effects ofstaurosporine, various other ki-
nase inhibitors had no significant effect on the NGF induc-
tion of transin, including inhibitors of the cyclic nucleotide-
dependent protein kinases (e.g., H8, HA1004). Further evi-
dence that activation of PKA, in particular, was not involved
in transin induction came from studies using the A126-1132
subclone of PC12 (VanBuskirk et al., 1985) in which NGF
was found to induce normal levels of transin mRNA expres-
sion in these PKA-deficient cells.
The notion that PKC is not the target ofstaurosporine's in-
hibitory effects is based on two observations. First, the PKC
inhibitors sphingosine and H-7 were found to have no
significant effect on the NGF induction of transin mRNAex-
pression at concentrations reported to block neurite exten-
sion in PC12 cells (Hall et al., 1988). Second, downregula-
tion ofPKC by pretreatment with high concentrations of TPA
also failed to inhibit the NGF induction of transin mRNA
levels. The lack of a direct role for PKC activation in transin
gene regulation is supported by observations that PKC-down-
regulated PC12 cellsshow unaffected NGF induction of vari-
ous early genes such as omithine decarboxylase (Reinhold
and Neet, 1986), late gene products such as N-CAM, GAP-
43, and SGC10 (Doherty et al., 1988; Costello et al ., 1990;
Sigmund et al., 1990), and neurite outgrowth (Reinhold and
Neet, 1986; Sigmund et al., 1990) . On the other hand, the
induction of other NGF-induced late genes in PC12 cells
does seem to be affected by PKC downregulation, including
tyrosine hydroxylase (Vyas et al., 1990). It should be noted,
however, that treatment with 1.0 j.M TPA for 24 h does not
completely downregulate PKC, but leaves ti5 % of the origi-
nal activity (Matthies et al ., 1987). If activation of PKC was
a necessary step in the NGF induction of transin and NF-M
gene expression, however, it seems likely that such a dra-
matic loss of PKC activity would produce an observable de-
crease in accumulated mRNA levels. On the other hand, TPA
may not downregulate all isoforms of PKC (e.g., Cooper et
al., 1989). It is possible, for example, that a non-downreg-
ulated isoform of PKC, which may comprise <5% of the
PKC activity in PC12 cells, may mediate entirely the NGF
induction of transin.
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In any case, the notion that PKC is not involved in the NGF
induction of transin mRNA expression in PC12 cells is in
stark contrast to the finding that PKC-downregulation com-
pletely blocks the EGF induction of transin in fibroblasts
(McDonnell et al ., 1990) . Indeed, this significant difference
in the effects of PKC downregulation on transin mRNA ex-
pression indicates that the signaling pathways for these two
growth factors may be quite distinct, at least at the level of
protein kinase involvement. The findings, however, that
staurosporine inhibits the NGF inductionofcfos, cjun, and
transin expression in PC12 cells, and that cfos and cjun in-
duction are likely to be directly involved in the EGF-
induction oftransin in fibroblasts (Kerret al., 1988) suggest
that Fos and Jun may be common elements in the NGF- and
EGF-signaling pathways.
The conclusion that PKC activation is not involved in the
NGF induction of transin, of course, leaves open the ques-
tion of how staurosporine acts. It seems likely, however, that
staurosporine acts via inhibition of one or another serine ki-
nase given reports of its relatively high affinity for this class
of kinase (Tamaoki et al ., 1986). This staurosporine-sen-
sitive kinase(s) is probably not, however, one of the cyclic
nucleotide-dependent protein kinases, since none of the iso-
quinoline sulfonamide derivatives (e.g., H-8, etc.) had any
observable effect on the NGF induction of transin. It also
seems unlikely that the staurosporine-sensitive kinase(s) in-
cludes PK-N-an NGF-responsive protein kinase (Rowland
et al., 1987). This conclusionis based on the report that 6-TG
is a more effective inhibitor of PK-N than 2-AP (Volonte et
al ., 1989), yet we found the opposite order of effectiveness
in blocking transin mRNA expression (see Fig. 1 A). On the
other hand, other NGF-responsive serine kinases (e.g.,
Blenis and Erickson, 1986; Matsuda et al., 1986; Brady et
al ., 1990; Landreth et al., 1990; Miyasaka et al., 1990), as
well as the trk protooncogene tyrosine kinase, cannot yet be
ruled out as possible targets of staurosporine's effects.
The Staurosporine-sensitive Protein Kinase Acts Both
Ranscriptionally and Pbsttranscriptionally
These studies also suggest that staurosporine is likely to act
at multiple steps in the NGF signaling pathway for transin
gene expression, and at least one of those steps is posttran-
scriptional. That is, when staurosporine was added simul-
taneously with NGF, it blocked the accumulation of transin
mRNA as measured by RNA blot analysis, -but had no
significant effect on the rate of transin mRNA productionas
measured by nuclear run-on assays. This would suggest that
staurosporine acts either to increase the rate of transin
mRNA degradation or to blocktransin mRNA elongation or
processing. Additional evidence that the rate of transin
mRNA transcription is not affected by the simultaneous ad-
dition of staurosporine with NGF can be gleaned from the
transient transfection studies. In these experiments, stauro-
sporine was observed to have only a small effect on the NGF-
induction of CAT activities in p750TRCATtransfected cells,
yet produced a dramatic decrease in steady-state transin
mRNA levels, presumably due to the lack ofeffect of stauro-
sporine on the stability ofCAT transcripts. Alternatively, the
p750TRCAT plasmid may simply not have contained DNA
sequences responsive to staurosporine.
In contrast to its effects with simultaneous addition,
staurosporine had qualitatively different effects on transin
1045gene expression when it was added after NGF In these ex-
periments, the addition ofstaurosporine either 30 min or 2 h
after NGF blocked transin mRNA expression, and this block
occurred at the transcriptional level. In nuclear run-on as-
says, for example, the rate of transin mRNA expression was
no different from that of non-NGF-treated cultures. These
dataindicate, therefore, that staurosporine has different effects
on the NGF induction of transin gene expression, and that
these different effects follow different time courses. It is not
known, however, whether all of these effects of staurosporine
are due to inhibition of a single protein kinase or whether
multiple kinases are involved.
These studies provide conflicting evidence, however, as to
whether Fos and Jun expression are intermediates in the NGF
signaling pathway. On the one hand, the inhibition of transin
mRNA expression by staurosporine correlated with its effect
on cfos and c-jun mRNA expression. Similarly, the various
PKC and PKA activators augmented the NGF induction of
cfos and cjun expression as it did with transin mRNA ex-
pression (see below) . On the other hand, Fos and Jun protein
levels have been shown to return to basal levels within 2 h af-
ter addition ofNGF (Curran and Morgan, 1985), yet addition
of staurosporine at this delayed time point still blocked the de
novo transcription of transin mRNA. These experiments
would indicate, therefore, that the posttranscriptional effects
of staurosporine on the NGF induction of transin mRNAex-
pression are likely not to involve Fos or Jun. The possibility
remains that some other, as yet unidentified IE gene product
is involved. If so, this IE gene product would most likely be
stably expressed and would require continual kinase acti-
vation.
Activation ofPKCorPKAAugment
the NGFInduction ofTfansin
Although activation of PKC is probably not a necessary step
for the NGF induction of transin mRNA expression, PKC
activation does potentiate the effects of NGF. This conclu-
sion is based on the observations that low concentrations of
TPA, which activate PKC in PC12 cells (Heasley and John-
son, 1989), synergized with NGF to induce higher levels of
transin mRNAexpression. In addition, both TPA and DOG
act synergistically with NGF to induce CAT activities in
transient transfection studies with pTR750CAT. Similarly,
various activators of PKA, such as dbcAMP and forskolin,
were also found to augment the NGF induction of transin,
and augmented the NGF induction of CAT activity in tran-
sient transfection assays. The absence of a cAMP-responsive
element in this 750-bp region of the transin promoter sug-
gests, however, that this effect may be indirect. In any case,
these data suggest that activation of any one of several ki-
nases may serve to upmodulate the expression of transin.
These findings are consistent, moreover, with the observa-
tions thatvarious PKC and PKA activators augment the NGF
induction ofvarious other late gene products, as well as neu-
rites, in PC12 cells (Guroff et al., 1981; Mann et al., 1989;
Costello et al., 1990; Damon et al., 1990; Glowacka and
Wagner, 1990). It should be noted, however, that none of
these PKC and PKA activators, alone or in various combina-
tions, induced transin mRNA expression or neurites in the
absence of NGR This would suggest that activation of these
kinases does not substitute for this staurosporine-sensitive
kinase in the NGF induction of transin.
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The NGFInductionof71ransinandNF-MGene
ExpressionMay InvolveDifferentSetsofKinases
Interestingly, the NGF induction of transin and NF-M tran-
scripts seemed to respond differently to different sets of
pharmacological agents. Although the NGF-induction of
both transin and NF-M were blocked by staurosporine and
the purine analogues, for example, 2-AP was found to have
a much more dramatic effect on NF-M than transin expres-
sion. This differential effect of 2-AP on the expression of
different gene products is consistent with earlier reports,
showing selective inhibition ofvarious IE gene products, in-
cluding cfos and c-myc (Zinn et al., 1988).
Studies using dbcAMP and forskolin showed that PKA ac-
tivation upmodulated the NGF induction of transin mRNA
levels, but had no significant effect on NGF-induced NF-M
mRNA levels. Vanadate, on the other hand, augmented the
NGF-induction of NF-M, but had no significant effect on
transin, suggesting that activation of some tyrosine kinase
may be involved in NF-M expression, but not that of transin.
Sincethe trk tyrosine kinase of the high affinity NGF recep-
tor is likely to be responsible for the NGF induction of both
transin and NF-M, it seems likely that effect of vanadate on
NF-M specifically involves some other tyrosine kinase-
mediated event in the NGF signaling pathway.
Expression ofRansin MayBeFunctionally Linked
toNeuriteExtension
These and other studies also provide evidence that transin
expression and neurite extension are correlated with one an-
other. In earlier work, we showed that subclones ofPC12 that
elaborated neurites in response to the fibroblast growth fac-
tors (FGF) were also shown to express transin mRNA tran-
scripts in response to these same growth factors (Machida
et al ., 1989). Activators of PKC and PKA, moreover, aug-
mented the NGF induction of both transin mRNAexpression
and neurite outgrowth in PC12 cells (see also End et al.,
1982; Glowacka and Wagner, 1990) . These studies are con-
sistent with earlier observations that various PKA and PKC
activators augmented the NGF-induced expression of vari-
ous neuronal traits, such as GAP-43 (Costello et al., 1990),
Thy-1 (Doherty et al., 1988), and N-CAM (Mann et al.,
1989). Thus, the effects of various protein kinase activators
and inhibitors on transin mRNAexpression and neurite out-
growth correlate with one another, suggesting that the path-
ways involved in their regulation may be functionally linked.
If transin is involved in neurite extension, it seems most
likely that it would serve to degrade extracellular matrix bar-
riers at the growth cone, as has been described for other
metalloproteinases (see Pittman, 1985; Pittman et al .,
1989). This possibility is consistent with the categorization
of transin as one member of a large metalloproteinase fam-
ily involved in extracellular matrix remodeling (Matrisian,
1990). Recently, we have shown that the transin protein is
also synthesized and released into the culture medium by
NGF-treated PC12 cells(Ciment, M., unpublished observa-
tions) .
The observation that different sets of protein kinases have
differential effects on the NGF-induced expressionoftransin
and NF-M may reflect, moreover, a general cellular strategy
for beingable to modulate independently the levels ofdiffer-
ent gene products to fit conditions in the cellular microen-
1046vironment. One might imagine, for example, that neuronal
cellsextending neurites into an environment in which axonal
growth is impeded by extracellular matrix barriers might re-
quire higher levels ofsecreted proteases, such as transin, and
lowerlevels of axonal structural elements, such as NF-M. It
is of interest to note, therefore, that laminin has been
reported to stimulate neurite extension via a pathway involv-
ing PKC (Bixby, 1989) . More direct evidence for a role of
transin in axonal outgrowth, however, awaits additional
studies.
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